[1]易佳音,张淑凤,冯慧芬,等.血清胆汁酸谱系测定在肝硬化诊断中的应用价值[J].郑州大学学报(医学版),2019,(06):922-926.[doi:10.13705/j.issn.1671-6825.2019.01.008]
　YI Jiayin,ZHANG Shufeng,FENG Huifen,et al.Application value of serum bile acid lineage measurement in diagnosis of cirrhosis[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2019,(06):922-926.[doi:10.13705/j.issn.1671-6825.2019.01.008]
点击复制

血清胆汁酸谱系测定在肝硬化诊断中的应用价值()
分享到：

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2019年06期
页码:
922-926
栏目:
应用研究
出版日期:
2019-11-20

文章信息/Info

Title:
Application value of serum bile acid lineage measurement in diagnosis of cirrhosis
作者:
易佳音; 张淑凤; 冯慧芬; 孙会卿; 王 斌; 赵 敬
郑州大学第五附属医院消化内科 郑州 450052
Author(s):
YI Jiayin; ZHANG Shufeng; FENG Huifen; SUN Huiqing; WANG Bin; ZHAO Jing
Department of Gastroenterology,the Fifth Affiliated Hospital,Zhengzhou University, Zhengzhou 450052
关键词:
肝硬化;  胆汁酸谱系;  Child-Pugh分级
Keywords:
cirrhosis;  bile acid lineage;  Child-Pugh classification
分类号:
R735.7
DOI:
10.13705/j.issn.1671-6825.2019.01.008
摘要:
目的:通过比较肝硬化患者与健康对照组血清中胆汁酸谱系的变化,探索胆汁酸谱系的测定在判断肝损伤、提示早期肝硬化、明确肝硬化临床分级及治疗中的应用价值。方法:将临床诊断为肝硬化的34例患者作为观察组,另选50例健康体检者作为正常对照组,用液相色谱-串联质谱法分别测定两组血清样本中5种未结合型胆汁酸及10种结合型胆汁酸的含量并进行比较分析。结果:与正常对照组相比,肝硬化组血清胆汁酸谱系检测值中未结合胆汁酸含量减少,结合胆汁酸含量明显增多(P<0.05)。正常对照组与肝硬化组Child-Pugh A分级间胆汁酸谱系含量差异有统计学意义(P<0.05); 不同Child-Pugh分级中,以甘氨胆酸(GCA)、牛磺胆酸(TCA)为主的8种胆汁酸会随着肝脏Child-Pugh分级的升高呈现出递增的趋势(P<0.05); 胆汁酸谱系诊断评估中诊断能力较高的有TCA(AUC=0.956),其次为牛磺鹅脱氧胆酸(TCDCA)(AUC=0.916)、GCA(AUC=0.912),阳性率比总胆汁酸、白蛋白、胆红素及凝血酶原高。结论:胆汁酸谱系可早期诊断肝损伤及提示早期肝硬化,并可作为Child-Pugh分级的有效补充。
Abstract:
Aim:By comparing the changes of serum bile acid lineage in patients with liver cirrhosis and healthy controls, the application value of the determination of bile acid lineage in judging liver injury, suggesting early cirrhosis, and deciding the clinical classification and treatment of cirrhosis was explored.Methods:Thirty-four patients with cirrhosis were chosen as observation group, and 50 healthy subjects,as normal control group. Tandem mass spectrometry LC-MS was used to determine 5 types of unbound bile acid and 10 types of bound bile acid in serum samples.Results:Compared with normal control group, the unbound bile acid content in the observation group was reduced, while the bound bile acid content was increased(P<0.05).There was a difference in bile acid lineage between the normal control group and patients with the Child-Pugh A grade(P<0.05). Among the patients with different Child-Pugh classifications, 8 kinds of bile acid especially glycocholic acid(GCA)and taurocholic acid(TCA)showed an increasing trend with the increase of Child-Pugh classification in the liver(P<0.05). Among the bile acid lineage,TCA had the highest diagnostic value for cirrhosis(AUC=0.956), followed by tauro-chenodeoxycholic acid(TCDCA)(AUC=0.916)and GCA(AUC=0.912). Their positive rates of diagnosis were higher than total bile acid, albumin, bilirubin and prothrombin.Conclusion:Bile acid lineage could be used in diagnosis of early liver injury and suggest early cirrhosis, and can be used as an effective supplement to Child-Pugh classification.

参考文献/References:

[1] 陈云茹,孙阳阳,邸莹,等.纤维介素2在慢性病毒性肝炎患者中的表达水平及临床意义[J].西安交通大学学报(医学版),2018,39(6):876
[2] 张伟,许荣放,田锐锋,等.阿德福韦酯与替比夫定联合恩替卡韦对失代偿期乙肝肝硬化患者肝功能及血清病毒学指标的影响[J].解放军医学杂志,2016,41(12):1041
[3] MARIOTTI V,STRAZZABOSCO M,FABRIS L,et al.Animal models of biliary injury and altered bile acid metabolism[J]. Biochim Biophys Acta Mol Basis Dis,2018,1864(4 Pt B):1254
[4] 余珈漫.血清胆碱酯酶、总胆汁酸检测在肝脏疾病诊断中的价值研究[J].中国医刊,2017,52(4):99
[5] 姜海华,王金英.血清总胆汁酸和胆碱酯酶及前白蛋白检测在肝硬化患者中的临床应用[J].中医临床研究,2017,9(7):126
[6] MA ZH,WANG XM,YIN PY,et al.Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury[J].Medicine(Baltimore),2019,98(31):e16717
[7] HORVATITS T,DROLZ A,ROEDL K,et al.Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis[J].Liver Int,2017,37(2):224
[8] LUO LA,AUBRECHT J,LI DZ,et al.Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans[J].PLoS One,2018,13(3):e0193824
[9] GOTTLIEB A,BECHMANN L,CANBAY A.The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids[J].Ann Hepatol,2018,17(3):340
[10]PURI P,DAITA K,JOYCE A,et al.The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids[J].Hepatology,2018,67(2):534
[11]LIU ZM,ZHANG ZF,HUANG M,et al.Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments[J].BMC Gastroenterol,2018,18(1):112
[12]VERBEKE L,MANNAERTS I,SCHIERWAGEN R,et al.FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis[J].Sci Rep,2016,6(1):33453
[13]ELBEL EE,LAVINE JE,DOWNES M,et al.hepatic nuclear receptor expression associates with features of histology in pediatric nonalcoholic fatty liver disease[J].Hepatol Commun,2018,2(10):1213
[14]MCGETTIGAN BM,MCMAHAN RH,LUO YH,et al.Sevelamer improves steatohepatitis, inhibits liver and intestinal farnesoid X receptor(FXR), and reverses innate immune dysregulation in a mouse model of non-alcoholic fatty liver disease[J].J Biol Chem,2016,291(44):23058
[15]WANG R,SHEPS JA,LIU L,et al.Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-/- mice[J].J Lipid Res,2019,60(1):85
[16]YU YR,LI SD,LIANG WF.Bona fide receptor for hepatitis B and D viral infections:mechanism,research models and molecular drug targets[J].Emerg Microbes Infect,2018,7(1):134
[17]ZHAO KT,LIU SH,CHEN YS,et al.Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B[J].Emerg Microbes Infect,2018,7(1):186
[18]MOUZANNAR K,FUSIL F,LACOMBE B,et al.Farnesoid X receptor-α is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo[J].FASEB J,2019,33(2):2472
[19]ZENG YL,LI ZX,SHANG J,et al.Efficient delivery of HBV NLS siRNAs into HepG2.2.15 cells for HBV inhibition through novel recombinant preS1tP proteins[J].Int J Mol Med,2018,42(2):1181
[20]PASSIOURA T,WATASHI K,FUKANO K,et al.De novo macrocyclic peptide inhibitors of hepatitis b virus cellular entry[J].Cell Chem Biol,2018,25(7):906

相似文献/References:

[1]管生,李明省,马南,等.超选择性经肝动脉化疗栓塞术联合射频消融治疗严重肝硬化合并小肝癌36例[J].郑州大学学报(医学版),2010,(04):666.
　[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(06):666.
[2]邹黎),毛建娜),郭长青).肝源性糖尿病80例临床分析[J].郑州大学学报(医学版),2010,(04):687.
　[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(06):687.
[3]陈汇,许冰#.内皮素受体拮抗剂对肝硬化大鼠转化生长因子β1和Ⅰ型胶原mRNA表达的影响[J].郑州大学学报(医学版),2011,(05):745.
　CHEN Hui,XU Bing.Effects of ET receptor antagonist on expression of TGFβ1 and collagen typeⅠmRNA in hepatic cirrhotic rats[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2011,(06):745.
[4]苏英),郭长青),高鹏),等.HCV所致慢性肝病中肝源性糖尿病的发生率与血糖水平[J].郑州大学学报(医学版),2012,(03):422.
[5]李焱,孙长宇#,周言.非侵入性指标诊断肝硬化食管静脉曲张的价值*[J].郑州大学学报(医学版),2013,(04):505.
　LI Yan,SUN Changyu,ZHOU Yan.Value of noninvasive parameters in dignosis of esophageal varices for patients with liver cirrhosis[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2013,(06):505.
[6]梁丽）,顾福嘉）,黄国美）#,等.脐血干细胞移植治疗失代偿期肝硬化效果观察*[J].郑州大学学报(医学版),2014,(04):552.
　LIANG Li,GU Fujia,HUANG Guomei,et al.Efficacy of umbilical cord blood stem cell transplantation for decompensated cirrhosis[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2014,(06):552.
[7]张香梅△,杨桂林,乐晓华,等.肝细胞癌合并乙型肝炎肝硬化患者癌组织中长链非编码RNA表达谱分析*[J].郑州大学学报(医学版),2015,(02):194.
　ZHANG Xiangmei,YANG Guilin,LE Xiaohua,et al.Expression profiles of long noncoding RNA in HCC patients suffering hepatitis B liver cirrhosis[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2015,(06):194.

备注/Memo

备注/Memo:
【作者简介】张淑凤,通信作者,女,1963年4月生,硕士,主任医师,研究方向:重症肝炎肝衰竭的肠道微生态,E-mail:sufei_zhang@126.com
更新日期/Last Update: 2019-11-20